Pharmacogenetics is an important example of the field of precision medicine, which aims to tailor medical treatment to each person or to a group of people. Pharmacogenomics looks at how your DNA affects the way you respond to drugs.
Genetic and functional approaches are the two main ones used in identification of genes that, when mutated, cause disease. In genetic approaches to the study of hereditary disease, genetic mapping methods are employed to identify the position within the human genome of a genetic factor influencing development of a disorder.
Diagnosis of infectious diseases by using PCR involves target amplification methods. Unlike phenotypic characteristics that may be variable, molecular amplification methods take advantage of the use of stable genotypic characteristics.
Clopidogrel sold under the brand name Plavix is a widely used antiplatelet agent to treat and prevent a variety of atherothrombotic diseases.
Research has implicated genetic variations in the CYP2C19 isozyme as at least partly responsible for the variable antiplatelet response seen with clopidogrel.
Apolipoprotein E is protein whose different isoforms are associated with variations in the level of fats and lipoproteins, and thus the occurrence of CARDIOVASCULAR diseases.
Real Time PCR testing enables qualitative detection of Y chromosomal microdeletions that directly affect this problem.
Breast and prostate cancer are the most common malignancies in humans. Their prognosis depends on the time of diagnosis.
With genetic testing, we enable early and quick identification and prediction of the causes of cardiovascular diseases, and thus obtaining a precise diagnosis and therapy.
Gluten intolerance, or Celiac disease is a condition characterized by inflammation of the lining of the small intestine as a result of an immune reaction caused by ingested gluten.
The panel includes simultaneous detection and identification of SARS-CoV-2, Influenza A+B and Human Respiratory Syncytial Virus (RSV) from respiratory samples.